BROWSE·page 155 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.2

Kraft Heinz Co

FIFTH AMENDMENT dated as of July 8, 2026 (this “Amendment”), among THE KRAFT HEINZ COMPANY, a Delaware corporation (“Kraft Heinz”), KRAFT HEINZ FOODS COMPANY, a Pennsylvania limited liability company (the “Parent Borrower”), the LENDERS party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.

WHEREAS, reference is made to the Credit Agreement dated as of July 8, 2022 (as amended by that certain First Amendment dated as of July 21, 2023, that certain Second Amendment dated as of June 21, 2024, that certain Third Amendment dated as of September 27, 2024, that certain Fourth Amendment dated as of July 8, 2025, and as further amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), among Kraft Heinz, the Parent Borrower, the other Borrowers from time to time party thereto, the Lenders from time to time party hereto and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Administrative Agent”), pursuant to which the Lenders have agreed to extend credit to the Borrowe

…

EX-10.2·10-Q·CIK 1637459·ACC 0001637459-26-000054·Filed Aug 05, 2026, 16:11 ET

EX-10.4

Kraft Heinz Co

THE KRAFT HEINZ COMPANY
2020 OMNIBUS INCENTIVE PLAN

2025 CASH RETAINER
2026 DEFERRED STOCK AWARD AGREEMENT

Unless defined in this award agreement (together with all exhibits and appendices attached thereto, this “Award Agreement”), capitalized terms will have the same meanings ascribed to them in The Kraft Heinz Company 2020 Omnibus Incentive Plan (as may be amended from time to time, the “Plan”).

Subject to your acceptance of this Award Agreement, you are hereby being granted an award of Deferred Stock (the “Deferred Stock”) as of the Grant Date set forth below (the “Grant Date”). Each share of Deferred Stock is a bookkeeping entry representing the right to receive one (1) share of The Kraft Heinz Company’s (the “Company”) common stock (the “Shares”) on the following terms and subject to the provisions of the Plan, which is incorporated herein by reference. In the event of a conflict between the provisions of the Plan and this Award Agreement, the provisions of the Plan will govern.

…

EX-10.4·10-Q·CIK 1637459·ACC 0001637459-26-000054·Filed Aug 05, 2026, 16:11 ET

EX-10.3

Kraft Heinz Co

THE KRAFT HEINZ COMPANY
2020 OMNIBUS INCENTIVE PLAN

2026 DEFERRED STOCK AWARD AGREEMENT

Unless defined in this award agreement (together with all exhibits and appendices attached thereto, this “Award Agreement”), capitalized terms will have the same meanings ascribed to them in The Kraft Heinz Company 2020 Omnibus Incentive Plan (as may be amended from time to time, the “Plan”).

Subject to your acceptance of this Award Agreement, you are hereby being granted an award of Deferred Stock (the “Deferred Stock”) as of the Grant Date set forth below (the “Grant Date”). Each share of Deferred Stock is a bookkeeping entry representing the right to receive one (1) share of The Kraft Heinz Company’s (the “Company”) common stock (the “Shares”) on the following terms and subject to the provisions of the Plan, which is incorporated herein by reference. In the event of a conflict between the provisions of the Plan and this Award Agreement, the provisions of the Plan will govern.

…

EX-10.3·10-Q·CIK 1637459·ACC 0001637459-26-000054·Filed Aug 05, 2026, 16:11 ET

EXHIBIT 10.1

Zevia PBC

Execution Version

FIRST AMENDMENT

TO LOAN AND SECURITY AGREEMENT

This FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of May 15, 2026, is by and among ZEVIA LLC, a Delaware limited liability company (the “Borrower”), the financial institutions party thereto from time to time as the Lenders and BANK OF AMERICA, N.A., a national banking association (“Bank of America”), as agent for the Lenders (in such capacity, the “Agent”).

RECITALS

A.      WHEREAS, the Borrower, Lenders and Agent have previously entered into that certain Loan and Security Agreement dated as of February 22, 2022 (as such agreement has been amended, restated, amended and restated, supplemented, or otherwise modified from time to time prior to the date hereof, the “Existing Loan Agreement”); and

B.       WHEREAS, the Borrower has requested that the Lenders and Agent amend the Existing Loan Agreement in certain respects, which Lenders and Agent are willing to do, in each case, all on the terms and subject to the conditions set forth below.

…

EX-10.1·10-Q·CIK 1854139·ACC 0001437749-26-025925·Filed Aug 05, 2026, 16:11 ET

EXHIBIT 10.3

Zevia PBC

SEVERANCE AGREEMENT

This **SEVERANCE AGREEMENT **(this “Agreement”) is entered into as of June 15, 2026 (the “Effective Date”), by and between Zevia PBC, a Delaware public benefit corporation (the “Company”), and *   Alexandre Ruberti         * (“Executive”).

1.         At-Will Employment. Executive acknowledges and agrees that Executive’s employment relationship with the Company is at will. This Agreement does not in any way alter Executive’s at-will status or limit the Company’s or Executive’s right to terminate Executive’s employment with the Company at any time, with or without Cause or advance notice.

2.           Definitions.

(a)      “Affiliate” means (i) all persons or entities directly or indirectly controlling, controlled by or under common control with the Company, (ii) all entities in which the Company directly or indirectly owns an equity interest; and (iii) all predecessors, successors and assigns of those Affiliates identified in (i) and (ii).

…

EX-10.3·10-Q·CIK 1854139·ACC 0001437749-26-025925·Filed Aug 05, 2026, 16:11 ET

EXHIBIT 10.2

Zevia PBC

June 10, 2026

Via email at alexandre.ruberti@gmail.com

Alexandre Ruberti

Re: Offer of Employment by Zevia PBC

Dear Alexandre,

I am very pleased to confirm our offer to you of employment with Zevia PBC (the “Company”). This offer and your employment relationship will be subject to the terms and conditions in this offer letter (the “Letter”). The Company reserves the right to modify job titles, reporting structures, wages, and benefits from time to time as it deems necessary and appropriate.

…

EX-10.2·10-Q·CIK 1854139·ACC 0001437749-26-025925·Filed Aug 05, 2026, 16:11 ET

EX-10.1

TTM TECHNOLOGIES INC

TTM TECHNOLOGIES, INC.
2023 INCENTIVE COMPENSATION PLAN

«Grant_Year» RESTRICTED STOCK UNIT AWARD GRANT NOTICE

NON-EMPLOYEE DIRECTOR

TTM Technologies, Inc. (the “Company”), pursuant to the TTM Technologies, Inc. 2023 Incentive Compensation Plan, as may be amended from time to time (the “Plan”), hereby grants to Participant a right to receive the number of shares of the common stock of the Company (the “Shares”) set forth below. This Restricted Stock Unit award (the “RSUs”) is subject to all of the terms and conditions as set forth herein, in the Restricted Stock Unit Award Agreement (the “Award Agreement”) and in the Plan, all of which are attached hereto and incorporated herein in their entirety.

Participant: «First_Name»«Middle_Initial»«Last_Name»

Date of Grant: «Grant_Date», «Grant_Year»

Vesting Commencement Date: «Vest Date»

Number of Shares subject to the RSUs: «RSU_Shares_Granted»

Expiration Date: Subject to termination as provided in Section 3(c) of the Award Agreement.

…

EX-10.1·10-Q·CIK 1116942·ACC 0001193125-26-335107·Filed Aug 05, 2026, 16:10 ET

EX-10.1

CARLSMED, INC.

Carlsmed, Inc.

Amended and Restated Non-Employee Director Compensation Policy Adopted: May 6, 2026

Each member of the Board of Directors (the “Board”) of Carlsmed, Inc. (the “Company”) who is not also serving as an employee of, or consultant to, the Company or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy (the “Policy”) for his or her Board service.

This Policy may be amended at any time in the sole discretion of the Board or the Compensation Committee of the Board (the “Compensation Committee”).

A.

Annual Retainer

…

EX-10.1·10-Q·CIK 1794546·ACC 0001794546-26-000016·Filed Aug 05, 2026, 16:10 ET

EX-10.2

CARLSMED, INC.

May 29, 2026

Carlsmed, Inc.

1800 Aston Avenue, Suite 100

Carlsbad, CA 92008

Attn: Michael Cordonnier

EMAIL: mike@carlsmed.com

Re:Loan and Security Agreement

Dear Mike:

Reference is hereby made to that certain Loan and Security Agreement dated as of December 20, 2022, as amended by that certain First Amendment to Loan and Security Agreement dated as of March 21, 2023, that certain Second Amendment to Loan and Security Agreement dated as of October 2, 2023, that certain Third Amendment to Loan and Security Agreement dated as of March 7, 2024, that certain Fourth Amendment to Loan and Security Agreement dated as of December 30, 2024, that certain Fifth Amendment to Loan and Security Agreement dated as of October 29, 2025, and that certain Sixth Amendment to Loan and Security Agreement dated as of December 23, 2025 (as so amended, and as may be further amended, restated, supplemented or otherwise modified from time to time, the Loan Agreement”), by and between CARLSMED, INC. (“Borrower”) and CUSTOMERS BANK (“Bank”). Capitalized terms used but not otherwise defined herein have the

…

EX-10.2·10-Q·CIK 1794546·ACC 0001794546-26-000016·Filed Aug 05, 2026, 16:10 ET

EX-10.2

Akebia Therapeutics, Inc.

AMENDMENT #4 TO SUPPLY AGREEMENT

This Amendment #4 (the “Amendment”) to the Supply Agreement by and between Akebia Therapeutics, Inc. (“Akebia”) and STA Pharmaceutical Hong Kong Limited(“STA”) is effective as of April 28, 2026 (the “Amendment Effective Date”). Akebia and STA are each referenced individually herein as a "Party" and together as the “Parties”.

WHEREAS,STA and Akebia entered into a Supply Agreement dated April 2, 2020, as amended on April 15, 2021, April 15, 2024, and August 15, 2025 (collectively, the “Supply Agreement”), under which STA manufactures vadadustat drug substance for purchase by Akebia; and

WHEREAS,the Parties desire to amend the Supply Agreement as set forth in this Amendment.

NOW, THEREFOREthe Parties agree as follows:

1.The third section of Article 2 of the Supply Agreement entitled “Affiliates” (and currently misnumbered as Section 2.1) is hereby renumbered to be “Section 2.3”. Any references to Section 2.1 in the Supply Agreement intending to be a reference to the section entitled “Affiliates” is hereby updated to refer to Section 2.3.

…

EX-10.2·10-Q·CIK 1517022·ACC 0001517022-26-000051·Filed Aug 05, 2026, 16:10 ET

EX-10.1

Akebia Therapeutics, Inc.

EIGHTH AMENDMENT TO LEASE

    This EIGHTH AMENDMENT TO LEASE (this “Amendment”) is entered into as of April 7, 2026 (the “Effective Date”), by and between CLPF-CAMBRIDGE SCIENCE CENTER, LLC, a Delaware limited liability company (“Landlord”), and AKEBIA THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

RECITALS

A.MA-Riverview/245 First Street, L.L.C., a Delaware limited liability company (the “Original Landlord”), and Tenant entered into that certain Office Lease Agreement dated as of December 3, 2013 (the “Original Lease”), as amended by that certain First Amendment to Lease dated December 15, 2014, that certain Second Amendment to Lease dated November 23, 2015, that certain Third Amendment to Lease dated July 25, 2016, that certain Fourth Amendment to Lease dated May 1, 2017, that certain Fifth Amendment to Lease dated April 9, 2018, that certain Sixth Amendment to Lease dated November 30, 2020 and that certain Seventh Amendment to Lease dated May 6, 2024 (collectively, the “Lease”), respecting certain premises consisting of approximately 59,216 rentable square feet on the 1

…

EX-10.1·10-Q·CIK 1517022·ACC 0001517022-26-000051·Filed Aug 05, 2026, 16:10 ET

EX-10.3

Akebia Therapeutics, Inc.

AMENDMENT #2 TO SUPPLY AGREEMENT

This Amendment #2 (the “Amendment”) to the Supply Agreement by and between Akebia Therapeutics, Inc. (“Akebia”) and STA Pharmaceutical Hong Kong Limited(“STA”) is effective as of April 28, 2026 (the “Amendment Effective Date”). Akebia and STA are each referenced individually herein as a "Party" and together as the “Parties”.

WHEREAS,STA and Akebia entered into a Supply Agreement dated February 10, 2021, as amended on October 15, 2024 (collectively, the “Supply Agreement”), under which STA manufactures vadadustat drug product for purchase by Akebia; and

WHEREAS,the Parties desire to amend the Supply Agreement as set forth in this Amendment.

NOW, THEREFOREthe Parties agree as follows:

1.The third section of Article 2 of the Supply Agreement entitled “Affiliates” (and currently misnumbered as Section 2.1) is hereby renumbered to be “Section 2.3”. Any references to Section 2.1 in the Supply Agreement intending to be a reference to the section entitled “Affiliates” is hereby updated to refer to Section 2.3.

…

EX-10.3·10-Q·CIK 1517022·ACC 0001517022-26-000051·Filed Aug 05, 2026, 16:10 ET